284 related articles for article (PubMed ID: 23904182)
21. Printing technologies in fabrication of drug delivery systems.
Kolakovic R; Viitala T; Ihalainen P; Genina N; Peltonen J; Sandler N
Expert Opin Drug Deliv; 2013 Dec; 10(12):1711-23. PubMed ID: 24256326
[TBL] [Abstract][Full Text] [Related]
22. Improvement of dissolution rate of indomethacin by inkjet printing.
Wickström H; Palo M; Rijckaert K; Kolakovic R; Nyman JO; Määttänen A; Ihalainen P; Peltonen J; Genina N; de Beer T; Löbmann K; Rades T; Sandler N
Eur J Pharm Sci; 2015 Jul; 75():91-100. PubMed ID: 25817804
[TBL] [Abstract][Full Text] [Related]
23. Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.
Zhang X; Wu D; Lai J; Lu Y; Yin Z; Wu W
J Pharm Sci; 2009 Feb; 98(2):665-75. PubMed ID: 18543294
[TBL] [Abstract][Full Text] [Related]
24. Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.
Fang D; Yang Y; Cui M; Pan H; Wang L; Li P; Wu W; Qiao S; Pan W
AAPS PharmSciTech; 2021 Jan; 22(1):37. PubMed ID: 33409925
[TBL] [Abstract][Full Text] [Related]
25. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
[TBL] [Abstract][Full Text] [Related]
26. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system.
Dannenfelser RM; He H; Joshi Y; Bateman S; Serajuddin AT
J Pharm Sci; 2004 May; 93(5):1165-75. PubMed ID: 15067693
[TBL] [Abstract][Full Text] [Related]
27. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines.
Pardeike J; Strohmeier DM; Schrödl N; Voura C; Gruber M; Khinast JG; Zimmer A
Int J Pharm; 2011 Nov; 420(1):93-100. PubMed ID: 21889582
[TBL] [Abstract][Full Text] [Related]
28. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
[TBL] [Abstract][Full Text] [Related]
30. Behavior of printable formulations of loperamide and caffeine on different substrates--effect of print density in inkjet printing.
Genina N; Fors D; Palo M; Peltonen J; Sandler N
Int J Pharm; 2013 Sep; 453(2):488-97. PubMed ID: 23769992
[TBL] [Abstract][Full Text] [Related]
31. A Proof of Concept for 3D Printing of Solid Lipid-Based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics.
Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ
Pharm Res; 2019 May; 36(7):102. PubMed ID: 31098846
[TBL] [Abstract][Full Text] [Related]
32. Colorimetry as Quality Control Tool for Individual Inkjet-Printed Pediatric Formulations.
Wickström H; Nyman JO; Indola M; Sundelin H; Kronberg L; Preis M; Rantanen J; Sandler N
AAPS PharmSciTech; 2017 Feb; 18(2):293-302. PubMed ID: 27738876
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of different substrates for inkjet printing of rasagiline mesylate.
Genina N; Janßen EM; Breitenbach A; Breitkreutz J; Sandler N
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1075-83. PubMed ID: 23563101
[TBL] [Abstract][Full Text] [Related]
34. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
35. Personalizing oral delivery of nanoformed piroxicam by semi-solid extrusion 3D printing.
Mathiyalagan R; Sjöholm E; Manandhar S; Lakio S; Rosenholm JM; Kaasalainen M; Wang X; Sandler N
Eur J Pharm Sci; 2023 Sep; 188():106497. PubMed ID: 37329925
[TBL] [Abstract][Full Text] [Related]
36. Edible solid foams as porous substrates for inkjet-printable pharmaceuticals.
Iftimi LD; Edinger M; Bar-Shalom D; Rantanen J; Genina N
Eur J Pharm Biopharm; 2019 Mar; 136():38-47. PubMed ID: 30630061
[TBL] [Abstract][Full Text] [Related]
37. Photocurable poly(ethylene glycol) as a bioink for the inkjet 3D pharming of hydrophobic drugs.
Acosta-Vélez GF; Zhu TZ; Linsley CS; Wu BM
Int J Pharm; 2018 Jul; 546(1-2):145-153. PubMed ID: 29705105
[TBL] [Abstract][Full Text] [Related]
38. Dropwise additive manufacturing of pharmaceutical products for melt-based dosage forms.
Içten E; Giridhar A; Taylor LS; Nagy ZK; Reklaitis GV
J Pharm Sci; 2015 May; 104(5):1641-9. PubMed ID: 25639605
[TBL] [Abstract][Full Text] [Related]
39. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
40. Making tablets for delivery of poorly soluble drugs using photoinitiated 3D inkjet printing.
Clark EA; Alexander MR; Irvine DJ; Roberts CJ; Wallace MJ; Yoo J; Wildman RD
Int J Pharm; 2020 Mar; 578():118805. PubMed ID: 31715351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
